These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16151400)

  • 1. Protozoan genomics for drug discovery.
    Chaudhary K; Roos DS
    Nat Biotechnol; 2005 Sep; 23(9):1089-91. PubMed ID: 16151400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing the impact of genomics on drug discovery and development.
    Crooke ST
    Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
    [No Abstract]   [Full Text] [Related]  

  • 4. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

  • 5. Will genomics revolutionise pharmaceutical R&D?
    Noble D
    Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress.
    Maitland-van der Zee AH; Aitchison K; Kirchheiner J;
    Eur J Pharm Sci; 2007 Jul; 31(3-4):151-5. PubMed ID: 17452095
    [No Abstract]   [Full Text] [Related]  

  • 7. The agony and ecstasy of "OMIC" technologies in drug development.
    Bilello JA
    Curr Mol Med; 2005 Feb; 5(1):39-52. PubMed ID: 15720269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a best strategy for drug discovery?
    Warne P; Page C
    Drug News Perspect; 2003 Apr; 16(3):177-82. PubMed ID: 12819816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical genomics versus orthodox drug development.
    Szymkowski DE
    Drug Discov Today; 2003 Feb; 8(4):157-9. PubMed ID: 12581708
    [No Abstract]   [Full Text] [Related]  

  • 10. Target-based drug discovery: is something wrong?
    Sams-Dodd F
    Drug Discov Today; 2005 Jan; 10(2):139-47. PubMed ID: 15718163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemogenomics in drug discovery.
    Kubinyi H
    Ernst Schering Res Found Workshop; 2006; (58):1-19. PubMed ID: 16708995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural genomics: a new era for pharmaceutical research.
    Liu Y; Luscombe NM; Alexandrov V; Bertone P; Harrison P; Zhang Z; Gerstein M
    Genome Biol; 2002; 3(2):REPORTS4004. PubMed ID: 11864367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MipTec: breaking down the silos of information.
    Yates I
    Drug Discov Today; 2004 Oct; 9(20):871-3. PubMed ID: 15475319
    [No Abstract]   [Full Text] [Related]  

  • 15. Iconix Pharmaceuticals, Inc.--removing barriers to efficient drug discovery through chemogenomics.
    Engelberg A
    Pharmacogenomics; 2004 Sep; 5(6):741-4. PubMed ID: 15335294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel biomedicine based on genome science.
    Baba Y
    Eur J Pharm Sci; 2001 Apr; 13(1):3-4. PubMed ID: 11292562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Will genes become an engine to the industry?].
    Nylund S; Sibakov M
    Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.